Bone marrow involvement in follicular lymphoma: Comparison of histology and flow cytometry as staging procedures

Bone marrow (BM) examination is a routine staging procedure in follicular lymphoma (FL). Commonly, both BM histology as well as flow cytometry (FCM) of BM aspirates are performed. In order to compare the diagnostic value of these two techniques, we retrospectively evaluated trephine BM biopsies and listmode data of patients with a confirmed diagnosis of FL, obtained in parallel during a 5-year period. One hundred and thirty nine specimens from 91 patients with FL were eligible for analysis. After joint review, nine cases (6.5%) were reclassified, either in histology (six cases) or FCM (three cases). Seventy nine specimens (57%) showed no infiltration with both methods. Sixty specimens (43%) were scored positive for BM involvement by any of the two techniques. Concordant positive results were obtained in 41 cases (68% of positive BM). False negative results were obtained by FCM in 14 cases (23% of positive BM) and by histology in five cases (8%). Discrepant results between BM histology and FCM are frequent in patients with FL, most likely due to the predominantly paratrabecular infiltration and fibrosis typical for FL. Due to the lower false negative rate, trephine BM biopsy remains crucial for the detection of BM involvement in FL.

[1]  J. Briones,et al.  Clinical utility of bone marrow flow cytometry in B‐cell non‐Hodgkin lymphomas (B‐NHL) , 2004, Histopathology.

[2]  G. Palestro,et al.  Flow cytometry in the bone marrow staging of mature B‐cell neoplasms , 2003, Cytometry. Part B, Clinical cytometry.

[3]  J. Matthews,et al.  Optimum trephine length in the assessment of bone marrow involvement in patients with diffuse large cell lymphoma. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[4]  L. Picker,et al.  Immunophenotypic analysis of hematogones (B-lymphocyte precursors) in 662 consecutive bone marrow specimens by 4-color flow cytometry. , 2001, Blood.

[5]  H. Höfler,et al.  Epstein-Barr Virus–Negative Hodgkin's Lymphoma After Mycosis Fungoides: Molecular Evidence for Distinct Clonal Origin , 2001, Modern Pathology.

[6]  J. Luider,et al.  Bone marrow staging of patients with non‐Hodgkin lymphoma by flow cytometry , 2000, Cancer.

[7]  C. de Wolf‐Peeters,et al.  Guidelines for subtyping small B-cell lymphomas in bone marrow biopsies , 1999, Virchows Archiv.

[8]  T. Habermann,et al.  Immunophenotypic analysis of peripheral blood and bone marrow in the staging of B-cell malignant lymphoma. , 1999, Blood.

[9]  J. Armitage,et al.  Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  R. Fisher,et al.  Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma. , 1998, The New England journal of medicine.

[11]  C. Dunphy Combining morphology and flow cytometric immunophenotyping to evaluate bone marrow specimens for B-cell malignant neoplasms. , 1998, American journal of clinical pathology.

[12]  M. Naughton,et al.  Bone marrow staging in patients with non‐hodgkin's lymphoma , 1998, Cancer.

[13]  F. Behm,et al.  U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: selection of antibody combinations. , 1997, Cytometry.

[14]  R. Gascoyne,et al.  U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: data analysis and interpretation. , 1997, Cytometry.

[15]  Gregory T Stelzer,et al.  U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: standardization and validation of laboratory procedures. , 1997, Cytometry.

[16]  M. M. Mac Manus,et al.  Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  K. Maclennan,et al.  Clinical stage 1 non-Hodgkin's lymphoma: long-term follow-up of patients treated by the British National Lymphoma Investigation with radiotherapy alone as initial therapy. , 1994, British Journal of Cancer.

[18]  P. Isaacson,et al.  Bone marrow trephine biopsy in lymphoproliferative disease. , 1992, Journal of clinical pathology.

[19]  M. Wolf,et al.  Value of bilateral bone marrow biopsy specimens in non-Hodgkin's lymphoma. , 1990, Journal of clinical pathology.

[20]  S. Swerdlow,et al.  bcl-2 expression by multicolor flow cytometric analysis assists in the diagnosis of follicular lymphoma in lymph node and bone marrow. , 2003, American journal of clinical pathology.

[21]  C. Palacio,et al.  Flow cytometry in the bone marrow evaluation of follicular and diffuse large B-cell lymphomas. , 2001, Haematologica.